Skip to main content
FinSpry Logo
FinSpry
VIR logo
VIR
(NASDAQ)
Vir Biotechnology, Inc.
$9.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Vir Biotechnology, Inc. (VIR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Vir Biotechnology, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy
Based on 9 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$21.43
↑ 129.44% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest VIR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Michael Ulz
Morgan Stanley
BuyReiterates
$23.00 → $27.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$20.00
Etzer Darout
Barclays
BuyMaintains
$30.00
Alec Stranahan
BofA Securities
BuyMaintains
$16.00
Roanna Ruiz
Leerink Partners
BuyReiterates
-
Phil Nadeau
TD Cowen
BuyMaintains
-
Paul Choi
Goldman Sachs
BuyMaintains
$21.00
Joseph Stringer
Needham
BuyMaintains
$18.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$18.00
Paul Choi
Goldman Sachs
BuyMaintains
$21.00

Frequently Asked Questions

What is the analyst consensus rating for VIR?

The analyst consensus rating for VIR is "Buy" based on 9 analyst recommendations.

What is the average price target for VIR?

The average 12-month price target for VIR is $21.43, representing an upside of 129.4% from the current price of $9.34.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.